Keihan Holdings Co.,Ltd. Logo

Keihan Holdings Co.,Ltd.

A conglomerate integrating transport, real estate, and retail for regional development.

9045 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
枚方市岡東町173番地の1
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Keihan Holdings Co., Ltd. is a Japanese conglomerate that functions as a holding company, primarily managing a group of businesses centered around transportation, real estate, and distribution. The company's core transportation segment operates railway and bus services, providing essential passenger transit. Its real estate division is engaged in the development, sale, and leasing of commercial and residential properties. The distribution arm manages various retail businesses. Through strategic oversight of its subsidiaries, Keihan Holdings aims to enhance the value and appeal of the areas along its transport lines by integrating its diverse services, which also extend into the leisure sector, to support regional development and provide a comprehensive lifestyle infrastructure.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-14 06:25
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 27.0 KB
2025-07-03 06:15
Regulatory News Service
訂正発行登録書
Japanese 8.8 KB
2025-07-03 06:10
Regulatory News Service
臨時報告書
Japanese 19.2 KB
2025-06-20 04:43
Registration Form
訂正発行登録書
Japanese 8.8 KB
2025-06-20 04:28
Regulatory News Service
臨時報告書
Japanese 26.5 KB
2025-06-17 04:35
Governance Information
内部統制報告書-第103期(2024/04/01-2025/03/31)
Japanese 28.2 KB
2025-06-17 04:30
Annual Report
有価証券報告書-第103期(2024/04/01-2025/03/31)
Japanese 1.7 MB
2025-06-17 04:30
Registration Form
確認書
Japanese 8.4 KB
2025-06-13 04:24
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 25.4 KB
2025-06-06 04:04
Registration Form
発行登録追補書類(株券、社債券等)
Japanese 58.2 KB
2025-05-16 03:50
Prospectus
発行登録書(株券、社債券等)
Japanese 28.8 KB
2025-05-14 07:58
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 26.2 KB
2025-04-15 02:41
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 25.9 KB
2025-03-14 06:44
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 26.1 KB
2025-02-14 03:01
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 26.0 KB

Automate Your Workflow. Get a real-time feed of all Keihan Holdings Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Keihan Holdings Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Developing novel cancer immunotherapies, including peptide vaccines and iPS-NKT cell therapies.
Japan 4594
Brilliant Future AB Logo
A data-driven survey platform to measure and improve employee & customer experiences.
Sweden BRILL
b-style holdings,Inc. Logo
Offers flexible staffing for homemakers and specialized recruitment for skilled professionals.
Japan 302A
BTS Group Logo
Helps organizations execute strategy via experiential learning for leadership and sales teams.
Sweden BTS
B.U Technology Logo
Commercializes university research via IP management, licensing, and new venture creation.
South Korea 230980
Advancing high-grade copper and precious metal projects from discovery to production.
Canada N/A
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland CTX
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan 6070
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan 4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.